Dr Sarah Best (left) and Dr Kate Sutherland (IMAGE)
Caption
Dr Sarah Best (left) and Dr Kate Sutherland from the Walter and Eliza Hall Institute, Melbourne, led a team that revealed a unique molecular signature in the blood that could be used to detect aggressive lung cancers with a simple blood test and identify patients who will respond to immunotherapies.
Credit
Walter and Eliza Hall Institute
Usage Restrictions
None
License
Licensed content